ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 385 out of 2429

$399K Total Retail Price of All Prescriptions

Rank: 441 out of 2429

263 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 263 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

0% of this provider’s 6,103 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 468 344 1 2
AMLODIPINE BESYLATE 367 307 2 4
FUROSEMIDE 290 234 3 5
METOPROLOL SUCCINATE 279 230 4 12
OMEPRAZOLE 263 211 5 7
WARFARIN SODIUM 258 257 6 11
DIOVAN 215 211 7 36
ISOSORBIDE MONONITRATE ER 213 188 8 55
ZOLPIDEM TARTRATE 208 174 9 28
SIMVASTATIN 202 180 10 1
CARVEDILOL 197 170 11 21
METOPROLOL TARTRATE 172 112 12 9
ATORVASTATIN CALCIUM 141 106 13 13
HYDROCODONE-ACETAMINOPHEN 139 46 S3 14 6
HYDROCHLOROTHIAZIDE 130 90 15 10
HYDRALAZINE HCL 115 77 16 81
TAMSULOSIN HCL 113 97 17 29
LEVOTHYROXINE SODIUM 111 70 18 3
NEXIUM 109 99 19 37
POTASSIUM CHLORIDE 106 91 20 14
IBUPROFEN 103 50 21 57
ATENOLOL 95 84 22 15
LIDODERM 86 65 23 109
PLAVIX 83 78 24 44
LANSOPRAZOLE 78 65 25 163
CRESTOR 78 56 25 25
METFORMIN HCL 75 45 27 8
CLOPIDOGREL 75 67 27 31
NAMENDA 66 66 29 35
GLIPIZIDE 62 28 30 47
FLUTICASONE PROPIONATE 58 40 31 39
ENALAPRIL MALEATE 58 43 31 32
GABAPENTIN 57 28 33 18
ADVAIR DISKUS 52 39 34 49
FAMOTIDINE 51 51 35 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.